Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530679) titled 'Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination' on April 1.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Crossover Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Jiangsu Province Centers for Disease Control and Prevention
Condition:
Cervical Cancer Prevention
Intervention:
Biological: 9-valent HPV vaccination at months 0 and 6
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 12, 2026
Target Sample Size: 360
To k...